Background and Purpose-Abnormal vascular remodeling triggered by hemodynamic stresses and inflammation is believed to be a key process in the pathophysiology of intracranial aneurysms. Numerous studies have shown infiltration of inflammatory cells, especially macrophages, into intracranial aneurysmal walls in humans. Using a mouse model of intracranial aneurysms, we tested whether macrophages play critical roles in the formation of intracranial aneurysms. Methods-Intracranial aneurysms were induced in adult male mice using a combination of a single injection of elastase into the cerebrospinal fluid and angiotensin II-induced hypertension. Aneurysm formation was assessed 3 weeks later. Roles of macrophages were assessed using clodronate liposome-induced macrophage depletion. In addition, the incidence of aneurysms was assessed in mice lacking monocyte chemotactic protein-1 (CCL2) and mice lacking matrix metalloproteinase-12 (macrophage elastase). Results-Intracranial aneurysms in this model showed leukocyte infiltration into the aneurysmal wall, the majority of the leukocytes being macrophages. Mice with macrophage depletion had a significantly reduced incidence of aneurysms compared with control mice (1 of 10 versus 6 of 10; PϽ0.05). Similarly, there was a reduced incidence of aneurysms in mice lacking monocyte chemotactic protein-1 compared with the incidence of aneurysms in wild-type mice (2 of 10 versus 14 of 20, PϽ0.05). There was no difference in the incidence of aneurysms between mice lacking matrix metalloproteinase-12 and wild-type mice. 
P otential roles of inflammation in the pathophysiology of intracranial aneurysms-both ruptured and unrupturedhave been suggested by observational and genetic studies. [1] [2] [3] [4] [5] [6] Macrophage infiltration has been well documented in both ruptured and unruptured intracranial aneurysms in humans. 2, 3, 7 A higher degree of inflammation in aneurysms seems to be associated with aneurysmal wall destruction and rupture. 3, 7 We have recently showed that macrophages and macrophage-derived cytokines are critical for hemodynamically induced outward vascular remodeling. 8, 9 Vascular remodeling coupled with inflammation is considered a key part in the pathophysiology of intracranial aneurysms. 4, 10 Sustained vascular remodeling may lead to aneurysmal growth and rupture. 1, 11 By mediating inflammation and hemodynamically induced vascular remodeling, macrophages may play critical roles in the development, growth, and rupture of intracranial aneurysms.
In this study, we examined whether macrophages are critical for the formation of intracranial aneurysms using a mouse model of intracranial aneurysms that replicates key features of human intracranial aneurysms. First, we assessed the effects of macrophage depletion by clodronate liposome on the formation of aneurysms. Second, aneurysm formation was assessed in mice lacking monocyte chemotactic protein-1 (MCP-1, CCL2). MCP-1 is a chemotactic factor that is critical for proper macrophage functions. MCP-1 knockout mice have reduced macrophage/monocyte counts and impaired macrophage functions. Therefore, they have been used as a genetic equivalent of mice with pharmacological depletion of macrophages and monocytes in various physiological and pathological settings. 12, 13 
Materials and Methods
Experiments were conducted in accordance with the guidelines approved by the University of California, San Francisco, Institutional Animal Care and Use Committee.
We used the elastase-induced intracranial aneurysms in 8-to 9-week-old hypertensive mice as previously described. 11 In this model, two well-known clinical factors associated with human intracranial aneurysms-hypertension and the disruption of elastic lamina-were combined to induce intracranial aneurysm formation in mice. We performed a single stereotaxic injection of elastase into the cerebrospinal fluid at the right basal cistern. A volume of 2.5 L elastase solution (17 mU) was injected at a rate of 0.2 L/min (Ultramicropump; World Precision Instruments). Hypertension was induced by a continuous subcutaneous infusion of angiotensin II at 1000 ng/kg/min for 3 weeks through an implanted osmotic pump (Alzet pump; Durect). 11, 14 Systolic blood pressure was measured in mice before treatment, 1 week after elastase injection, and 2 weeks after elastase injection using the tail cuff method. After 3 weeks, we euthanized the mice and perfused the animals with bromophenol blue dye. Two blinded observers assessed the formation of intracranial aneurysms by examining the circle of Willis and its major branches under a dissecting microscope (10ϫ). Intracranial aneurysms were operationally defined as a localized outward bulging of the vascular wall in the circle of Willis or in its major primary branches, as previously described. 10, 11 After inspecting the circle of Willis, the whole brain samples were frozen for immunohistochemical staining.
Macrophage Depletion
Macrophage depletion was achieved by an intravenous injection of liposome-encapsulated dichloromethylene diphosphonate (clodronate liposome). 15 We used 8-to 9-week-old male C57BL/6J mice (nϭ10 in each group). Clodronate was a gift from Roche Diagnostics GmbH (Mannheim, Germany). Animals received clodronate liposome intravenously 2 days before elastase and angiotensin II treatment. This regimen was reported to cause a reduction of macrophages to Ͻ10% of the baseline count. 9, 16 Animals in the control group received the same volume of phosphate-buffered saline-containing liposome (PBS liposome). We assessed the efficiency of macrophage depletion by examining macrophages in the spleen using immunohistochemistry, as previously described. 9, 16 Incidence of Aneurysms in MCP-1 Knockout Mice and Matrix Metalloproteinase-12 Knockout Mice
In addition, the incidence of aneurysms was assessed in MCP-1 knockout mice and matrix metalloproteinase-12 (MMP-12) knockout mice (nϭ10). Wild-type mice with the same background (both C57BL/6J) were used as control mice (nϭ20).
Immunohistochemical Analysis
Details of immunohistochemical analysis are described in the Supplemental Data (available at http://stroke.ahajournals.org).
Statistical Analysis
All results were expressed as meanϮSD. Differences between multiple groups were analyzed by 1-way analysis of variance followed by the Tukey-Kramer post hoc test. Fisher exact test was used to analyze the incidence of aneurysms. Statistical significance was taken at PϽ0.05. Figure 1 shows representative intracranial aneurysms in hypertensive mice that received a single injection of elastase into the cerebrospinal fluid. Large saccular aneurysm formation was found along the circle of Willis or its major branches, which is consistent with our previous study ( Figure  1A-D) . 11 Most aneurysms were Ͼ250 m in diameter, approximately 2 to 5 times larger than their parent arteries, as we previously reported ( Figure 1A-D) . Some mice had multiple aneurysms ( Figure 1D) .
Results

Presence of Macrophages in Experimental Intracranial Aneurysm
A cerebral artery from the sham operation group revealed an endothelial cell lining with a thin layer of smooth muscle cells, as previously described ( Figure 2A ). 11 In contrast, intracranial aneurysms had a partially thickened vascular wall with inflammatory cell infiltration ( Figure 2B ). Endothelial cell layers seemed to be generally intact, but smooth muscle cell layers had thickened in the area with intense inflammatory cell infiltration.
Pan-leukocyte staining using anti-CD45 antibody and macrophage staining using anti-CD68 antibody in the cerebral artery from the sham operation group showed a lack of inflammatory cells and macrophage infiltration ( Figures 2C  and 2E ). In intracranial aneurysms, numerous leukocytes (CD45-positive cells) were detected in the adventitia and media of the aneurysmal wall ( Figure 2D ), especially in the thickened part of aneurysmal wall, which is generally consistent with observations in human intracranial aneurysms. 2, 3, 7 Macrophage staining showed macrophage infiltration into the aneurysmal wall with a distribution similar to that of leukocytes ( Figure 2F -G). Double staining with anti-CD68 and anti-CD45 revealed that the majority of leukocytes in intracranial aneurysms in this model were macrophages ( Figure 2H ).
Effects of Macrophage Depletion on Intracranial Aneurysm Formation
Ten mice underwent macrophage depletion treatment with clodronate liposome 2 days before the induction of intracranial aneurysms, and another 10 mice received PBS liposome. All 20 mice received a single stereotaxic injection of elastase into the cerebrospinal fluid to disrupt the elastic lamina and a continuous infusion of angiotensin II to induce hypertension.
When we examined the mice 3 weeks after aneurysm induction, mice that received macrophage depletion treatment using clodronate liposome had a reduced incidence of intracranial aneurysms compared with mice that received PBS liposome (mice with intact macrophages; 1 of 10 versus 6 of 10; 10% versus 60%, PϽ0.05; Figure 3A) , indicating a critical role of macrophages in the formation of intracranial aneurysms in this model.
Although there were abundant macrophages in the intracranial aneurysms from a PBS liposome-treated mouse (Figure 3D-E Quantification of macrophages (nϭ5 in each group) showed that the number of macrophages was higher in the Figure 3H ).
Immunohistochemical staining for CD68-positive cells (monocyte/macrophage) in the spleen (nϭ5 at each time point) was used to assess the efficiency and time course of clodronate liposome treatment as previously described (Figure 4A-B) . 9, 16 Treatment with clodronate liposome decreased the CD68-positive area in the spleen by 88% from the baseline (28.8Ϯ4.1 versus 3.2Ϯ1.0%, PϽ0.05), showing an effective macrophage/monocyte reduction by the clodronate treatment. At 2 weeks, the CD68-positive area returned to baseline (28.8Ϯ4.1 versus 23.1Ϯ2.6%).
Angiotensin II treatment caused hypertension in both groups. After 1 week and 2 weeks, systolic blood pressure was higher than the baseline. Macrophage depletion treatment did not affect systolic blood pressure ( Figure 4C ).
Reduced Incidence of Intracranial Aneurysm in MCP-1 Knockout Mice
Because MCP-1 knockout mice have reduced monocyte/macrophage counts and impaired macrophage functions, 17 we used MCP-1 knockout mice to further test the critical role of macrophages in the formation of intracranial aneurysms. Twenty wild-type mice and ten MCP-1 knockout mice underwent intracranial aneurysm induction.
MCP-1 knockout mice had a lower incidence of aneurysms compared with wild-type mice (2 of 10 versus 14 of 20; 20% versus 70%, PϽ0.05; Figure 5A ). Immunohistochemical staining of cerebral arteries for macrophages showed a lack of macrophage infiltration in MCP-1 knockout mice ( Figure  5B ). Quantification of macrophages in the middle cerebral artery (nϭ5 in each group) showed reduced macrophage infiltration to the middle cerebral artery in MCP-1 knockout mice compared with macrophage infiltration in wild-type mice (2.8Ϯ1.4 versus 10.9Ϯ0.8, PϽ0.05; Figure 5E ).
Macrophages produce MMPs that are critical for vascular remodeling. 8, 9 Previously, we have shown there is high activity of MMPs in intracranial aneurysms using this model. 11 The MMP inhibitor, doxycycline, significantly reduced the incidence of intracranial aneurysms. 11 MMP-9 knockout mice, but not MMP-2 knockout mice, had a reduced incidence of intracranial aneurysms. 11 Whereas MMP-9 is the main gelatinase produced by macrophages, MMP-12 represents the major elastase from macrophages. MMP-12 could be the proteinase responsible for facilitating structural changes of elastic lamina, resulting in physiological and pathological vascular remodeling. 18 Therefore, we investigated the roles of MMP-12 in the formation of intracranial aneurysms. However, there was no difference in the incidence of intracranial aneurysms between MMP-12 knockout mice and wild-type mice (50% versus 70%). Moreover, immunohistochemical staining for macrophages (CD68-positive cells) showed a similar number of macrophages that accumulated in MMP-12 knockout mice compared with the number of macrophages in wild-type mice (9.4Ϯ2.3 versus 10.9Ϯ0.8; Figure 5E ).
Continuous infusion of angiotensin II increased systolic blood pressure from the baseline after 1 week and 2 weeks in MCP-1 knockout mice and MMP-12 knockout mice. There was no significant difference between wild-type mice and MCP-1 or MMP-12 knockout mice at 1 week and 2 weeks ( Figure 5F ).
Discussion
In this study, we have shown the critical roles of macrophages in the formation of intracranial aneurysms in mice. We used a recently developed intracranial aneurysm model in which intracranial aneurysms were induced by a combination of single stereotaxic injection of elastase into the cerebrospinal fluid and pharmacologically induced hypertension in mice. Intracranial aneurysms in this mouse model closely resemble histological changes that are observed in human intracranial aneurysms. 11 Using this model, we first showed infiltration of inflammatory cells, mostly macrophages, into the aneurysmal wall. Second, mice with pharmacological depletion of macrophages had a significantly reduced incidence of intracranial aneurysms compared with mice with intact macrophages. In addition, MCP-1 knockout mice, mice with reduced monocyte/macrophage counts and impaired macrophage function, had a significantly reduced incidence of intracranial aneurysms compared with wild-type mice. These findings strongly indicate that macrophages play critical roles in the formation of intracranial aneurysms in this model, especially during the early stages of aneurysmal formation and growth.
Intracranial aneurysms are commonly found in locations where abnormal hemodynamic stresses are exerted on the vascular wall. 19 Abnormal hemodynamic stresses trigger an inflammatory process by activating endothelial cells and monocytes/macrophages. These cells secrete proteinases, including MMPs and elastases. 1 MMPs can destabilize the vascular wall directly by facilitating vascular remodeling by digestion of the vascular matrix and indirectly by activating and releasing of other proteinases and angiogenic factors. 20 We have previously shown critical roles of macrophages and MMPs in adaptive vascular remodeling of large arteries. 9 Intracranial aneurysms may represent a result of maladaptive vascular remodeling in which inflammatory cells maintain active and abnormal remodeling processes that lead to aneurysm growth and rupture. 1 Similar to our study, Aoki et al used MCP-1 knockout mice in a different mouse intracranial aneurysm model in which intracranial aneurysms were induced by a combination of 4 manipulations over 5 months: treatment with ␤ aminopropionitrile (irreversible lysyl oxidase inhibitor), unilateral carotid artery ligation, bilateral posterior renal artery ligation, and high-salt drinking water. 21 In their study, aneurysmal changes, defined as disruption of elastic lamina with or without the formation of aneurysms, were less frequent in MCP-1 knockout mice compared with wild-type mice, which is generally consistent with our data. 21 In their study, there was a weak trend for MCP-1 knockout mice to have a reduced incidence of aneurysms compared with wild-type mice (10% versus 20%), whereas our study showed a statistically significant reduction of the incidence of aneurysms in MCP-1 knockout mice compared with wild-type mice (20% versus 70%). Such difference between these two studies might be due to a difference in severity of the phenotype between these two models. Aneurysms induced by a single injection of elastase into the cerebrospinal fluid in hypertensive mice tend to be larger and macroscopically apparent. 11 In contrast, the mouse aneurysm model used by Aoki et al yielded smaller aneurysms with more subtle histological changes. 21, 22 Previously, potential roles of MMPs were shown in the formation of intracranial aneurysms. 6, 11, 22 We have shown that a broad-spectrum inhibitor of MMPs can suppress the formation of intracranial aneurysms. Although MMP-2 was not critical for the formation of intracranial aneurysms, mice lacking MMP-9 had a reduced incidence of aneurysms. 11 Macrophage-derived MMP-9 may be playing critical roles in the formation of intracranial aneurysms. 22 In this study, we assessed roles of another key MMP that is produced by macrophages-MMP-12, a macrophage elastase. However, a lack of MMP-12 did not affect the incidence of aneurysms. Unlike MMP-9, MMP-12 may not play a significant role in the formation of intracranial aneurysms. Because exogenous elastase was used to induce aneurysms in our model, it may be the case that the early processes that require endogenous elastases such as MMP-12 may have been bypassed in this model. Alternatively, roles of macrophages and MMPs may be different between different stages-early and late stagesof aneurysm formation and growth.
Clodronate liposome, the treatment we used to deplete macrophages, may have unknown side effects. However, in our experiments, the animals that received clodronate liposome did not show any apparent signs of adverse effects. In our previous study, we have shown that clodronate liposome treatment did not have effects on other leukocyte subpopulation, platelets, or red blood cells. 9 Our methods to deplete macrophages did not completely deplete the target cell population. This may have resulted in an incomplete suppression of aneurysm formation. Alternatively, other cell types may have had compensated for the relative lack of macrophages.
In summary, data from this study strongly indicated critical roles of macrophages in the formation of intracranial aneurysms in mice. Macrophages and macrophage-derived cytokines may be maintaining abnormal and active aneurysmal wall remodeling that lead to aneurysmal growth and rupture. Pharmacological therapy that modifies inflammation mediated by macrophages may be studied for the prevention of progression, growth, and rupture of intracranial aneurysms. 
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Immunohistochemical analysis
Immunohistochemical staining was performed using rat monoclonal anti mouse CD45 for pan-leukocytes and rat monoclonal anti mouse CD68 for macrophages as previously described. 1 Representative aneurysms from the wild-type mice that received elastase and angiotensin-II treatment and control middle cerebral artery (immediately distal of the bifurcation from the internal carotid artery) from the wild-type mice that received a stereotaxic injection of PBS and a continuous infusion of PBS through osmotic pump were used to identify inflammatory cell types that infiltrated into aneurysms. Results from the two observers were averaged.
